000 | 01984 a2200577 4500 | ||
---|---|---|---|
005 | 20250515230816.0 | ||
264 | 0 | _c20110131 | |
008 | 201101s 0 0 eng d | ||
022 | _a1557-8852 | ||
024 | 7 |
_a10.1089/cbr.2009.0695 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBarrett, John A | |
245 | 0 | 0 |
_aComparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution. _h[electronic resource] |
260 |
_bCancer biotherapy & radiopharmaceuticals _cJun 2010 |
||
300 |
_a299-308 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_a3-Iodobenzylguanidine _xanalogs & derivatives |
650 | 0 | 4 |
_aAnimal Structures _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aBone Marrow _xmetabolism |
650 | 0 | 4 |
_aBradycardia _xchemically induced |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIodine Radioisotopes _xchemistry |
650 | 0 | 4 |
_aIsotope Labeling _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aNeuroblastoma _xpathology |
650 | 0 | 4 |
_aRadiopharmaceuticals _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aTissue Distribution |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aJoyal, John L | |
700 | 1 | _aHillier, Shawn M | |
700 | 1 | _aMaresca, Kevin P | |
700 | 1 | _aFemia, Frank J | |
700 | 1 | _aKronauge, James F | |
700 | 1 | _aBoyd, Marie | |
700 | 1 | _aMairs, Robert J | |
700 | 1 | _aBabich, John W | |
773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 25 _gno. 3 _gp. 299-308 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.2009.0695 _zAvailable from publisher's website |
999 |
_c19926773 _d19926773 |